Results 41 to 50 of about 5,850 (214)

Otologic Wegener's Granulomatosis [PDF]

open access: yesActa Otorrinolaringologica (English Edition), 2013
Wegener’s granulomatosis (WG) is a systemic vasculitic disease characterized by necrotizing granulomas and vasculitis of small vessels.1,2 Upper airway tract involvement is frequent over the course of the disease.1,3 Cytoplasmatic pattern antineutrophil cytoplasmic antibodies (c-ANCA) are highly specific for WG in the active phase.1,3 Proteinase 3-ANCA
Mesquita-Oliveira, P   +3 more
openaire   +3 more sources

The Effect of Vitamin D3 Supplementation on the Risk of Falls in a General Population—The Finnish Vitamin D Trial

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background The impact of vitamin D on fall incidence remains controversial. We studied the effect of 5 years of vitamin D3 supplementation on the risk of falls in a double‐blind, placebo‐controlled randomized trial with generally healthy, community‐dwelling men and women in Finland.
Toni Rikkonen   +9 more
wiley   +1 more source

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab

open access: yesArthritis &Rheumatology, Volume 78, Issue 5, Page 1134-1144, May 2026.
Objective The objective of the study was to determine risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) after reinduction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post hoc analysis of the RITAZAREM clinical trial.
Ellen Romich   +62 more
wiley   +1 more source

Linked help from bacterial proteins drives autoantibody production in small vessel vasculitis. [PDF]

open access: yes, 2018
The small vessel vasculitides granulomatosis with polyangiitis (GPA) and microscopic polyangiitis are associated with autoantibodies to neutrophil cytoplasm antigens (ANCA), principally proteinase-3 (PR3) and myeloperoxidase (MPO).
Oliveira, DBG
core   +1 more source

Treatment of Wegener’s granulomatosis [PDF]

open access: yesReumatismo, 1993
Treatment and outcome of 111 patients who fell ill with Wegener's granulomatosis (WG) between 1966 and 1990 were analysed retrospectively. Two regimens of treatment were distinguished: "conventional" treatment, i.e. daily application of cyclophosphamide/corticosteroids (FAUCI scheme) or azathioprine/corticosteroids or corticosteroids alone, and "stage ...
Lutz Briedigkeit   +5 more
openaire   +6 more sources

Aortic Valve Perforation in Pediatric Granulomatosis With Polyangiitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Granulomatosis with polyangiitis, formerly Wegener's granulomatosis, is a rare antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis primarily affecting the respiratory tract and kidneys. Cardiovascular involvement, particularly valvular disease, is rare, especially in pediatric patients.
Libor Svoboda   +5 more
wiley   +1 more source

Linfoma de Burkitt en un portador de granulomatosis de Wegener

open access: yesActa Médica Costarricense, 2005
Se reporta el caso de un paciente costarricense portador de granulomatosis de Wegener, en tratamiento con ciclofosfamida y prednisona, quien desarrolla un linfoma de Burkitt que lo lleva a la muerte.
Kryssia Rodríguez-Castro   +1 more
doaj   +2 more sources

Dysphagia as the Sole Presentation of Lateral Medullary Syndrome in an Octagerian: A Diagnostic Challenge

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Lateral medullary syndrome (LMS) or Wallenberg's syndrome is usually caused by a cerebrovascular accident of the vertebral artery or the posterior inferior cerebellar artery (PICA), leading to damage to the dorsolateral aspects of the medulla oblongata.
Abera Kuma   +5 more
wiley   +1 more source

Wegener’s granulomatosis mimicking inflammatory bowel disease and presenting with chronic enteritis

open access: yesInternational Medical Case Reports Journal, 2013
Kamyar Shahedi,1,2 Ramy Magdy Hanna,1,2 Oleg Melamed,1,2 James Wilson2,31Department of Medicine Olive-View UCLA Medical Center, Sylmar, CA, 2David Geffen School of Medicine at UCLA, Los Angeles, CA, 3UCLA Medical Center-UCLA Stone Center, Los Angeles, CA,
Shahedi K, Hanna RM, Melamed O, Wilson J
doaj  

ANCA-associated vasculitis – Should we change the standard of care? [PDF]

open access: yes, 2015
Collaborative clinical trials over the last 25 years have revolutionised the care of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This has led to production of management recommendations and standards of care.
Bligny   +45 more
core   +1 more source

Home - About - Disclaimer - Privacy